中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age

文献类型:期刊论文

作者Wu, Leilei2; Yao, Qianlan2; Li, Yixue2,3; Lin, Ping3; Feng, Fangyoumin3; Li, Hong3; Li, Yixue4; Pang, Shichao5; Jian, Chen1; Feng, Fangyoumin6
刊名SCIENTIFIC REPORTS
出版日期2017
卷号7期号:-页码:3471
关键词Histone deacetylase4 (HDAC4) Ischemia/reperfusion Myocardial function
ISSN号2045-2322
DOI10.1038/s41598-017-02992-7
文献子类Article
英文摘要Recent cancer researches pay more attention to younger patients due to the variable treatment response among different age groups. Here we investigated the effectiveness of neoadjuvant radiation on the survival of younger and older patients in stage II/III rectal cancer. Data was obtained from Surveillance, Epidemiology, and End Results (SEER) database (n = 12801). Propensity score matching was used to balance baseline covariates according to the status of neoadjuvant radiation. Our results showed that neoadjuvant radiation had better survival benefit (Log-rank P = 3.25e-06) and improved cancer-specific 3-year (87.6%; 95% CI: 86.4-88.7% vs. 84.1%; 95% CI: 82.8-85.3%) and 5-year survival rates (78.1%; 95% CI: 76.2-80.1% vs. 77%; 95% CI: 75.3-78.8%). In older groups (> 50), neoadjuvant radiation was associated with survival benefits in stage II (HR: 0.741; 95% CI: 0.599-0.916; P = 5.80e-3) and stage III (HR: 0.656; 95% CI 0.564-0.764; P = 5.26e-08). Interestingly, neoadjuvant radiation did not increase survival rate in younger patients (< = 50) both in stage II (HR: 2.014; 95% CI: 0.9032-4.490; P = 0.087) and stage III (HR: 1.168; 95% CI: 0.829-1.646; P = 0.372). Additionally, neoadjuvant radiation significantly decreased the cancer-specific mortality in older patients, but increased mortality in younger patients. Our results provided new insights on the neoadjuvant radiation in rectal cancer, especially for the younger patients.
学科主题Science & Technology - Other Topics
WOS关键词TOTAL MESORECTAL EXCISION ; PROPENSITY SCORE METHODS ; COLORECTAL-CANCER ; PREOPERATIVE RADIOTHERAPY ; POSTOPERATIVE CHEMORADIOTHERAPY ; MICROSATELLITE INSTABILITY ; LOCAL RECURRENCE ; ADJUVANT CHEMOTHERAPY ; RANDOMIZED-TRIAL ; YOUNG-PATIENTS
语种英语
WOS记录号WOS:000403318400025
出版者NATURE PUBLISHING GROUP
版本出版稿
源URL[http://202.127.25.144/handle/331004/802]  
专题中国科学院上海生命科学研究院营养科学研究所
作者单位1.Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Gen Surg, Sch Med, Shanghai 201600, Peoples R China;
2.Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China;
3.Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China;
4.Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Shanghai 200433, Peoples R China;
5.Shanghai Jiao Tong Univ, Sch Math Sci, Dept Stat, Shanghai 200240, Peoples R China;
6.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China,
推荐引用方式
GB/T 7714
Wu, Leilei,Yao, Qianlan,Li, Yixue,et al. Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age[J]. SCIENTIFIC REPORTS,2017,7(-):3471.
APA Wu, Leilei.,Yao, Qianlan.,Li, Yixue.,Lin, Ping.,Feng, Fangyoumin.,...&,.(2017).Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age.SCIENTIFIC REPORTS,7(-),3471.
MLA Wu, Leilei,et al."Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age".SCIENTIFIC REPORTS 7.-(2017):3471.

入库方式: OAI收割

来源:上海营养与健康研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。